Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrazolopyridine derivatives as inhibitors of β-Adrenergic receptor kinase 1

Pyrazolopyridine derivatives as inhibitors of β-Adrenergic receptor kinase 1

US Patent 7910602 · Granted Mar 22, 2011

Estimated economic value: $7,996,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Soluble guanylate cyclase activators for treating portal hypertension2025
Isoxazolidines as RIPK1 inhibitors and use thereof2024
Alkoxy pyrazoles as soluble guanylate cyclase activators2023
Colony stimulating factor-1 receptor (CSF-1R) inhibitors2022
Azetidine compounds as GPR119 modulators for the treatment of diabetes, obesity,2019
Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obes2018
Substituted indanone compounds as GPR119 modulators for the treatment of diabete2018
Fluoromethyl-substituted pyrrole carboxamides iv2017
3-oxo-tetrahydro-furo[3,2-b]pyrrol-4(5H)-yl) derivatives II2017
Substituted fused heterocycles as GPR119 modulators for the treatment of diabete2017
3-oxo-tetrahydro-furo[3,2-B]pyrrol-4(5H)-yl) derivatives I2017
Fluoromethyl-substituted pyrrole carboxamides as CaV2.2 calcium channel blockers2017